[1]
2014. Pharmacovigilance in oncology: pattern of spontaneous notifications, incidence of adverse drug reactions and under-reporting . Brazilian Journal of Pharmaceutical Sciences. 50, 2 (Apr. 2014), 411–422. DOI:https://doi.org/10.1590/S1984-82502014000200021.